scispace - formally typeset
Search or ask a question
Journal ArticleDOI

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Rafael Lozano1, Mohsen Naghavi1, Kyle J Foreman2, Stephen S Lim1  +192 moreInstitutions (95)
15 Dec 2012-The Lancet (Elsevier)-Vol. 380, Iss: 9859, pp 2095-2128
TL;DR: The Global Burden of Diseases, Injuries, and Risk Factors Study 2010 aimed to estimate annual deaths for the world and 21 regions between 1980 and 2010 for 235 causes, with uncertainty intervals (UIs), separately by age and sex, using the Cause of Death Ensemble model.
About: This article is published in The Lancet.The article was published on 2012-12-15 and is currently open access. It has received 11809 citations till now. The article focuses on the topics: Mortality rate & Years of potential life lost.

Summary (6 min read)

Introduction

  • Cause-specific mortality is arguably one of the most fundamental metrics of population health.
  • For the remaining deaths which are not medically certified, many different data sources and diagnostic approaches must be used from surveillance systems, demographic research sites, surveys, censuses, disease registries, and police records to construct a consolidated picture of causes of death in various populations.
  • These efforts often include very specific steps undertaken for different data sources and are frequently poorly documented.
  • GBD revisions for 1999, 2000, 2001, 2002, 2004, and 2008 have used these compositional models to allocate deaths according to three broad cause groups: communicable, maternal, neonatal, and nutritional causes; noncommunicable diseases; and injuries.
  • 38 Given the profusion of statistical modeling options, an important innovation has been the reporting of out-of-sample predictive validity to document the performance of complex models.

Data and methods

  • Some general aspects of the analytical framework such as the creation of the 21 GBD regions and the full hierarchical cause list including the mapping of the International Classification of Diseases and Injuries (ICD) to the GBD cause list are reported elsewhere.
  • While results are reported in this paper at the regional level for 1990 and 2010, the cause of death analysis has been undertaken at the country level for 187 countries from 1980 to 2010.
  • Using longer time series improves the performance of many types of estimation models; data prior to 1980, however, are much sparser for developing countries so the authors have restricted the analysis to 1980-2010.

Database development

  • Over the five year duration of the GBD 2010 study, the authors have sought to identify all published and unpublished data sources relevant to estimating causes of death for 187 countries from 1980 to 2010.
  • Web Table 1a provides a summary of the siteyears of data identified by broad type of data system and, similarly, Web Table 1b illustrates the number of site-years by GBD region.
  • Of the GBD regions, subSaharan Africa Central has the most limited evidence base with data on only 27 causes from at least one country.
  • In addition, there is country to country variation in the detail used to report causes of death included in national reporting lists, namely the basic tabulation list for ICD9, the ICD10 tabulation list, three digit and four digit detail, and special reporting lists.
  • Verbal autopsy data collected through sample registration systems, demographic surveillance systems, or surveys Verbal autopsy (VA) is a means for ascertaining the cause of death of individuals and the cause-specific mortality fractions in populations with incomplete vital registration systems.

Population-based cancer registries

  • Population-based cancer registries provide an important source of data on incidence of cancers in various countries.
  • The authors identified 2,715 site-years of cancer registry data across 93 countries.
  • The log of the MI ratio has been estimated as a function of national income per capita with random effects for country, year, and age.
  • The estimated mortality to incidence ratios have been used to map cancer registry data on incidence to expected deaths which have been incorporated into the database.
  • MI ratios by country, age, and sex are available on request.

Police reports

  • In most countries, police and crime reports are an important source of information for some types of injuries, notably road injuries and inter-personal violence.
  • The police reports used in this analysis were collected from published studies, national agencies, and institutional surveys such as the United Nations Crime Trends survey and the WHO Global Status Report on Road Safety Survey.30,41.
  • The authors identified 32 site-years of burial and mortuary data in 11 countries from ministries of health, published reports, and mortuaries themselves.
  • The authors also identified 52 surveys/censuses covering injury mortality across 65 survey/census years.
  • Surveillance data on the number of maternal deaths, or the maternal mortality ratio multiplied by births, were converted into cause fractions by dividing by the total number of deaths estimated in the reproductive age groups.

Health facility data

  • The authors chose to only incorporate deaths due to injury from this source because of known bias.
  • In settings where a data source does not capture all deaths in a population, the cause composition of deaths captured may be different than those that are not.
  • At the global level, the number of deaths estimated in 2010 for ARI and diarrhea for example differ by 0·9% and 1·2%, respectively, between models that include all data and those that exclude data where under-five death registration is below 70% complete.
  • Garbage codes are causes of death that should not be identified as underlying causes of death but have been entered as the underlying cause of death on death certificates.
  • For the GBD 2010, the authors have identified causes that should not be assigned as underlying cause of death at a much more detailed level.

Cause of Death Ensemble modeling (CODEm)

  • For all major causes of death except for HIV/AIDS and measles, the authors have used cause of death ensemble modeling – 133 causes in the cause list and three other special aggregates.
  • In addition, four families of statistical models are developed using covariates: mixed effects linear models of the log of the death rate, mixed effects linear models of the logit of the cause fraction, spatial-temporal Gaussian process regression (ST-GPR) models of the log of the death rate, and ST-GPR of the logit of the cause fraction.
  • 3) Based on out-of-sample predictive validity, the best performing model or ensemble is selected.
  • Web Table 6 summarizes the performance of the CODEm models developed for 133 causes in the cause list for which the authors exclusively use CODEm and three special aggregates in the GBD 2010.
  • In all cases the out-of-sample performance is worse (larger RMSE) than the in-sample performance.

Negative binomial models

  • For 13 causes, the number of deaths observed in the database is too low to generate stable estimates of out-of-sample predictive validity.
  • For these causes, the authors developed negative binomial models using plausible covariates.
  • These causes are identified in Web Table 5.
  • For these negative binomial models, standard model building practice was followed where plausible covariates were included in the model development and reverse stepwise procedures followed for covariate inclusion.
  • Uncertainty distributions were estimated using both uncertainty in the regression betas for the covariates and from the gamma distribution of the negative binomial.

Fixed proportion models

  • In 28 cases where death is a rare event, the authors have first modeled the parent cause in the GBD hierarchy using CODEm and then allocated deaths to specific causes using a fixed proportion.
  • Proportions have been computed using all available data in the database and are fixed over time, but, depending on data density, allowed to vary by region, age, or sex.
  • Finally, cellulitis, decubitus ulcer, other skin and subcutaneous diseases, abscess, impetigo, and other bacterial skin diseases all varied by age and sex.
  • The meta-regression have generated region-age-sex estimates with uncertainty of etiological fractions for diarrhea, LRI, meningitis, chronic kidney disease, maternal conditions, cirrhosis.
  • In the cases of cirrhosis, liver cancer, maternal conditions, and chronic kidney disease, the studies or datasets on etiology identify primary cause as assessed clinically; for diarrhea, LRI, and meningitis, etiology is based on laboratory findings.

Natural History Models

  • For a few selected causes, there is evidence that cause of death data systems do not capture sufficient information for one of two reasons.
  • Second, there are reasons to believe that there is systematic misclassification of deaths in cause of death data sources, particularly for congenital syphilis,54,55 whooping cough,56 measles,57 and HIV/AIDS.58.
  • In the case of HIV/AIDS, a hybrid approach has been used.
  • For 36 countries, with complete and high quality vital registration systems, the authors have used CODEm, in consultation with UNAIDS.
  • For the remaining countries, the authors have used the estimates with uncertainty by age and sex provided directly by UNAIDS based on their 2012 revision.

Mortality Shock Regressions

  • To estimate deaths directly due to natural disasters or collective violence, the authors use a different approach.
  • Details of this approach are outlined in Murray et al.59.
  • To develop the covariate on battle deaths during collective violence, the authors used data from the Armed Conflict Database from the International Institute for Strategic Studies (1997-2011), the Uppsala Conflict Data Program(UCDP)/PRIO Armed Conflict Dataset (1946-present), and available data from complete VR systems.
  • The relationships between under-five mortality and adult mortality and the disaster and collective violence covariates are estimated using 43 empirical observations for disasters and 206 empirical observations for collective violence (only years with over 1 per 10,000 crude death rate from shocks are kept in this analysis).
  • The relationship is estimated for excess mortality from these data sources by first subtracting from observed mortality rates the expected death rates in shock years using the methods outlined in Murray et al.59.

Combining Results for Individual Causes of Death to Generate Final Estimates

  • Given that the authors develop single cause models, it is imperative as a final step to ensure that individual cause estimates sum to the all-cause mortality estimate for each age-sex-country-year group.
  • The authors use a simple algorithm called CoDCorrect; at the level of each draw from the posterior distribution of each cause, they proportionately rescale each cause such that the sum of the cause-specific estimates equals the number of deaths from all causes generated from the demographic analysis.47.
  • The authors have chosen levels for each cause based on consideration of the amount and quality of available data.
  • Because there are substantially more data on all cardiovascular causes from verbal autopsy studies than for specific cardiovascular causes, the authors have designated “all cardiovascular” as a level 1 cause for CoDCorrect.

Ranking lists

  • For the presentation of leading causes of death, the level at which one ranks causes is subject to debate.
  • Given the GBD cause list tree structure, multiple options are possible such as all cancers versus sitespecific cancers.
  • The authors have opted to produce tables of rankings using the level of disaggregation that seems most relevant for public health decision-making.
  • The reference standard has been constructed using the lowest observed death rate in each age group across countries with a population greater than five million (see Murray et al39 for details).
  • Because the all-cause mortality analysis is undertaken, however, for more detailed age-groups up to age 110, the authors are able to take into account the mean age of death over 80 in each country-year-sex group in computing YLLs.

Epidemiological Factors

  • To help understand the drivers of change in the numbers of deaths by cause or region, the authors have decomposed change from 1990 to 2010 into growth in total population, change in population age- and sex-structure, and change in age- and sex-specific rates.
  • The difference between 2010 deaths and the population growth and aging scenario is the difference in death numbers due to epidemiological change in age- and sex-specific death rates.
  • Each of these three differences is also presented as a percent change with reference to the 1990 observed death number.
  • Further details on the data and methods used for specific causes of death is available on request.

Global Causes of Death

  • The GBD cause list divides causes into three broad groups.
  • With declining age-specific death rates from all three groups of causes, including noncommunicable diseases, the global shift towards noncommunicable diseases and injuries as leading causes of death is being driven by population growth and aging, and not by increases in age-sex-cause specific death rates.
  • Among communicable diseases, notably lower respiratory infections (194 thousand), diarrhea (77 thousand) and meningitis (46 thousand) account for the remaining neonatal deaths.
  • A number of causes have much larger uncertainty intervals than adjacent causes in the rank list.
  • At both time periods, there is substantial variation across regions in the relative importance of different causes, with communicable diseases and related causes being much more important in parts of sub-Saharan Africa and parts of Asia than in North Africa, and vascular diseases and cancer predominating in most other regions.

Discussion

  • The GBD 2010 is the most comprehensive and systematic analysis of causes of death undertaken to date.
  • The global health community can now draw on annual estimates of mortality, by age and sex, for 21 regions of the world, for each year from 1980 to 2010, for 235 separate causes, each with 95% uncertainty intervals to aid interpretation.
  • An innovative dimension of the GBD 2010 has been the addition of estimates of deaths due to different diarrhea and lower respiratory infection (LRI) pathogens.
  • First, cause of death data even in settings with medical certification may not always accurately capture the underlying cause of death.

Author Contributions

  • CJLM, ADL, and RL prepared the first draft.
  • RL, MN, KF, SL, KS, ADL, and CJLM finalized the draft based on comments from other authors and reviewer feedback.
  • ADL and CJLM conceived of the study and provided overall guidance.
  • All other authors developed cause-specific models, reviewed results, provided guidance on the selection of key covariates, and reviewed the manuscript.

Figures and Tables

  • Decomposition analysis of the change of global death numbers by broad cause groups from 1990 to 2010 into total population growth, population aging and changes in age-,sex-and cause-specific death rates.
  • Percentage of global deaths for females and males in 1990 and 2010 by cause and age.
  • The colors represent the various level one causes; blue is for non-communicable diseases, red is for communicable, maternal, neonatal and nutritional conditions, and green is for injuries.
  • The dashed lines signify descending order in rank, while the solid lines signify ascending order in rank.
  • Some cause abbreviations used in the figure are lower respiratory infections (“LRI”); ischemic heart disease (“IHD”); chronic obstructive pulmonary disorder (“COPD”); protein energy malnutrition (“PEM”); tuberculosis (“TB”); neonatal encephalopathy (“N Enceph”); neonatal sepsis (“N Sepsis”); road injuries (“Road Inj”); cancer (“CA”); and chronic kidney disease (“CKD”).

70 Bates M, O’Grady J, Mudenda V, Shibemba A, Zumla A. New global estimates of malaria deaths.

  • Global Enterics Mutli-Center Study (GEMS): University of Maryland School of Medicine.
  • Differences in the etiology of communityacquired pneumonia according to site of care: A population-based study.
  • Respiratory syncytial virus infection in elderly and high-risk adults.
  • Lancet 2011; 377: 1438–47. 92 Beaglehole R, Yach D. Globalisation and the prevention and control of non-communicable disease: the neglected chronic diseases of adults.
  • Population Health Metrics Research Consortium gold standard verbal autopsy validation study: design, implementation, and development of analysis datasets.

Did you find this useful? Give us your feedback

Citations
More filters
Journal ArticleDOI
TL;DR: The inflammatory and cellular mechanisms of asthma and COPD are compared and the differences in inflammatory cells and profile of inflammatory mediators are highlighted to better understand the underlying cellular and molecular mechanisms in order to develop new treatments in areas of unmet need.
Abstract: Asthma and chronic obstructive pulmonary disease (COPD) both cause airway obstruction and are associated with chronic inflammation of the airways. However, the nature and sites of the inflammation differ between these diseases, resulting in different pathology, clinical manifestations and response to therapy. In this review, the inflammatory and cellular mechanisms of asthma and COPD are compared and the differences in inflammatory cells and profile of inflammatory mediators are highlighted. These differences account for the differences in clinical manifestations of asthma and COPD and their response to therapy. Although asthma and COPD are usually distinct, there are some patients who show an overlap of features, which may be explained by the coincidence of two common diseases or distinct phenotypes of each disease. It is important to better understand the underlying cellular and molecular mechanisms of asthma and COPD in order to develop new treatments in areas of unmet need, such as severe asthma, curative therapy for asthma and effective anti-inflammatory treatments for COPD.

286 citations

Journal ArticleDOI
TL;DR: It is found that patients are being prescribed approximately 3 times greater opioid medications than needed following upper-extremity surgical procedures, and surgeons should consider customizing their opioid prescriptions on the basis of anatomic location and procedure type to prescribe the optimal amount of opioids while avoiding dissemination of excess opioids.
Abstract: Background: Although adequate management of postoperative pain with oral analgesics is an important aspect of surgical procedures, inadvertent overprescribing can lead to excess availability of opioids in the community for potential diversion. The purpose of our study was to prospectively evaluate opioid consumption following outpatient upper-extremity surgical procedures to determine opioid utilization patterns and to develop prescribing guidelines. Methods: All patients undergoing outpatient upper-extremity surgical procedures over a consecutive 6-month period had the following prospective data collected: patient demographic characteristics, surgical details, anesthesia type, and opioid prescription and consumption patterns. Analysis of variance and post hoc comparisons were performed using t tests, with the p value for multiple pairwise tests adjusted by the Bonferroni correction. Results: A total of 1,416 patients with a mean age of 56 years (range, 18 to 93 years) were included in the study. Surgeons prescribed a mean total of 24 pills, and patients reported consuming a mean total of 8.1 pills, resulting in a utilization rate of 34%. Patients undergoing soft-tissue procedures reported requiring fewer opioids (5.1 pills for 2.2 days) compared with fracture surgical procedures (13.0 pills for 4.5 days) or joint procedures (14.5 pills for 5.0 days) (p < 0.001). Patients who underwent wrist surgical procedures required a mean number of 7.5 pills for 3.1 days and those who underwent hand surgical procedures required a mean number of 7.7 pills for 2.9 days, compared with patients who underwent forearm or elbow surgical procedures (11.1 pills) and those who underwent upper arm or shoulder surgical procedures (22.0 pills) (p < 0.01). Procedure type, anatomic location, anesthesia type, age, and type of insurance were also all significantly associated with reported opioid consumption (p < 0.001). Conclusions: In this large, prospective evaluation of postoperative opioid consumption, we found that patients are being prescribed approximately 3 times greater opioid medications than needed following upper-extremity surgical procedures. We have provided general prescribing guidelines, and we recommend that surgeons carefully examine their patients’ opioid utilization and consider customizing their opioid prescriptions on the basis of anatomic location and procedure type to prescribe the optimal amount of opioids while avoiding dissemination of excess opioids.

285 citations

Journal ArticleDOI
TL;DR: How the story of hepatitis C virus infection ends will largely be determined by the extent to which these rapidly advancing opportunities overcome the growing challenges and by the vigor of the public health response.
Abstract: We are entering an important new chapter in the story of hepatitis C virus (HCV) infection. There are clear challenges and opportunities. On the one hand, new HCV infections are still occurring, and an estimated 185 million people are or have previously been infected worldwide. Most HCV-infected persons are unaware of their status yet are at risk for life-threatening diseases such as cirrhosis and hepatocellular carcinoma (HCC), whose incidences are predicted to rise in the coming decade. On the other hand, new HCV infections can be prevented, and those that have already occurred can be detected and treated--viral eradication is even possible. How the story ends will largely be determined by the extent to which these rapidly advancing opportunities overcome the growing challenges and by the vigor of the public health response.

282 citations

Journal ArticleDOI
06 Apr 2018
TL;DR: A better understanding of how to prevent, diagnose and manage COPD in both rural and urban settings would make a real difference in countries of need, and awareness campaigns and health programmes have the potential to revolutionise the diagnosis and management of COPD and COPD exacerbations.
Abstract: An estimated 328 million people have COPD worldwide [3]. In 15 years, COPD is expected to become the leading cause of death worldwide [3]. Three billion people worldwide are exposed to toxic amounts of HAP every day and HAP accounts for 3.5–4 million deaths annually [11]. Those who have never smoked tobacco can still get COPD – think ‘biomass COPD’.

281 citations

Journal ArticleDOI
04 Feb 2019
TL;DR: There is an extensive, high-quality evidence to suggest that improvements can be achieved for key CVD risk factors such as hypertension, dyslipidemia, tobacco use, and elevated hemoglobin A1c.
Abstract: Cardiovascular diseases (CVDs) are a leading cause of death globally. This article explores the evidence surrounding community pharmacist interventions to reduce cardiovascular events and related mortality and to improve the management of CVD risk factors. We summarize a range of systematic reviews and leading randomized controlled trials and provide critical appraisal. Major observations are that very few trials directly measure clinical outcomes, potentially owing to a range of challenges in this regard. By contrast, there is an extensive, high-quality evidence to suggest that improvements can be achieved for key CVD risk factors such as hypertension, dyslipidemia, tobacco use, and elevated hemoglobin A1c. The heterogeneity of interventions tested and considerable variation of the context under which implementation occurred suggest that caution is warranted in the interpretation of meta-analyses. It is highly important to generate evidence for pharmacist interventions in developing countries where a majority of the global CVD burden will be experienced in the near future. A growing capacity for clinical registry trials and data linkage might allow future research to collect clinical outcomes data more often.

279 citations

References
More filters
Journal ArticleDOI
TL;DR: The results for 20 world regions are presented, summarizing the global patterns for the eight most common cancers, and striking differences in the patterns of cancer from region to region are observed.
Abstract: Estimates of the worldwide incidence and mortality from 27 cancers in 2008 have been prepared for 182 countries as part of the GLOBOCAN series published by the International Agency for Research on Cancer. In this article, we present the results for 20 world regions, summarizing the global patterns for the eight most common cancers. Overall, an estimated 12.7 million new cancer cases and 7.6 million cancer deaths occur in 2008, with 56% of new cancer cases and 63% of the cancer deaths occurring in the less developed regions of the world. The most commonly diagnosed cancers worldwide are lung (1.61 million, 12.7% of the total), breast (1.38 million, 10.9%) and colorectal cancers (1.23 million, 9.7%). The most common causes of cancer death are lung cancer (1.38 million, 18.2% of the total), stomach cancer (738,000 deaths, 9.7%) and liver cancer (696,000 deaths, 9.2%). Cancer is neither rare anywhere in the world, nor mainly confined to high-resource countries. Striking differences in the patterns of cancer from region to region are observed.

21,040 citations

Journal ArticleDOI
TL;DR: The longitudinal glomerular filtration rate was estimated among 1,120,295 adults within a large, integrated system of health care delivery in whom serum creatinine had been measured between 1996 and 2000 and who had not undergone dialysis or kidney transplantation.
Abstract: Background End-stage renal disease substantially increases the risks of death, cardiovascular disease, and use of specialized health care, but the effects of less severe kidney dysfunction on these outcomes are less well defined. Methods We estimated the longitudinal glomerular filtration rate (GFR) among 1,120,295 adults within a large, integrated system of health care delivery in whom serum creatinine had been measured between 1996 and 2000 and who had not undergone dialysis or kidney transplantation. We examined the multivariable association between the estimated GFR and the risks of death, cardiovascular events, and hospitalization. Results The median follow-up was 2.84 years, the mean age was 52 years, and 55 percent of the group were women. After adjustment, the risk of death increased as the GFR decreased below 60 ml per minute per 1.73 m2 of body-surface area: the adjusted hazard ratio for death was 1.2 with an estimated GFR of 45 to 59 ml per minute per 1.73 m2 (95 percent confidence interval, 1....

9,642 citations

Journal ArticleDOI
Stephen S Lim1, Theo Vos, Abraham D. Flaxman1, Goodarz Danaei2  +207 moreInstitutions (92)
TL;DR: In this paper, the authors estimated deaths and disability-adjusted life years (DALYs; sum of years lived with disability [YLD] and years of life lost [YLL]) attributable to the independent effects of 67 risk factors and clusters of risk factors for 21 regions in 1990 and 2010.

9,324 citations

Book
01 Jan 1996
TL;DR: This is the first in a planned series of 10 volumes that will attempt to "summarize epidemiological knowledge about all major conditions and most risk factors" and use historical trends in main determinants to project mortality and disease burden forward to 2020.
Abstract: This is the first in a planned series of 10 volumes that will attempt to "summarize epidemiological knowledge about all major conditions and most risk factors;...generate assessments of numbers of deaths by cause that are consistent with the total numbers of deaths by age sex and region provided by demographers;...provide methodologies for and assessments of aggregate disease burden that combine--into the Disability-Adjusted Life Year or DALY measure--burden from premature mortality with that from living with disability; and...use historical trends in main determinants to project mortality and disease burden forward to 2020." This first volume includes chapters summarizing results from the project as a whole. (EXCERPT)

7,154 citations

Related Papers (5)
Frequently Asked Questions (15)
Q1. What have the authors contributed in "Global and regional mortality from 235 causes of death for 20 age- groups in 1990 and 2010: a systematic analysis" ?

In this paper, the authors proposed a method to provide timely and accurate information on causes of death by age and sex. 

Improved estimation of mortality from HIV/AIDS including uncertainty in the future will come both from continued progress in the estimation of the time course of the HIV epidemic by UNAIDS as well as further data on the levels of adult mortality in some key countries such as Nigeria. These are important both for the prioritization of existing treatments, such as rotavirus or pneumococcal vaccines, but also for the development of future technologies. When large multi-center studies such as GEMS publish their results this will be an important addition to the analysis ; future revisions of the GBD should make use of these results as they become available. The authors believe that for causes where the magnitude of these corrections is comparatively large, future research should be targeted to trying to build a better understanding of the strengths and weaknesses of the various data sources, whether epidemiological or demographic. 

Because of known bias in the epidemiological composition of burial and mortuary data, the authors only use information on the fraction of injuries due to specific sub-causes from these sources. 

Much could be learned about causes of death in countries where death certification is poor through the more widespread testing and application of recent advances in verbal autopsy methods which greatly reduce heterogeneity in diagnostic practices across populations where VA is currently used. 

By the post-neonatal period, causes of death are dominated by diarrhea, LRI, and other infectious diseases such as measles, among others. 

Because of the variety of data sources and their associated biases, cause of death assessments are inherently uncertain and subject to vigorous debate. 

The ambition to estimate mortality from 235 causes with uncertainty for 187 countries over time from 1980 to 2010 means that many choices about data sources, quality adjustments to data and modeling strategies had to be made. 

Although the authors report more disaggregated causes, because of considerations related to public health programs, the authors have chosen to include diarrheal diseases, lower respiratory infections, maternal causes, cerebrovascular disease, liver cancer, cirrhosis, drug use, road injury, exposure to mechanical forces, animal contact, homicide, and congenital causes in the ranking list. 

In addition, four families of statistical models are developed using covariates: mixed effects linear models of the log of the death rate, mixed effects linear models of the logit of the cause fraction, spatial-temporal Gaussian process regression (ST-GPR) models of the log of the death rate, and ST-GPR of the logit of the cause fraction. 

60–62The relationships between under-five mortality and adult mortality and the disaster and collective violence covariates are estimated using 43 empirical observations for disasters and 206 empirical observations for collective violence (only years with over 1 per 10,000 crude death rate from shocks are kept in this analysis). 

For 13 causes, the number of deaths observed in the database is too low to generate stable estimates of out-of-sample predictive validity. 

Opportunities for strengthening death registration, cause of death certification, and the more widespread use of verbal autopsy exist. 

The coefficients from these regressions and the disaster and collective violence covariates are used to predict excess deaths from these two causes. 

There are reasons, however, to also be concerned that deaths recorded in systems with low coverage may be biased towards selected causes that are more likely to occur in hospital. 

Although at the draw level the same scalar is applied to all causes, the net effect of CoDCorrect is to change the size of more uncertain causes by more than is done for more certain causes, a desirable property.